Mar 4 |
Why Amphastar Pharmaceuticals Is A Strong Buy: Growth, Valuation, And Strategic Acquisitions
|
Mar 2 |
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Q4 2023 Earnings Call Transcript
|
Mar 1 |
Amphastar Pharmaceuticals, Inc. (AMPH) Q4 2023 Earnings Call Transcript
|
Feb 29 |
Q4 2023 Amphastar Pharmaceuticals Inc Earnings Call
|
Feb 28 |
Amphastar Pharmaceuticals (AMPH) Surpasses Q4 Earnings and Revenue Estimates
|
Feb 28 |
Amphastar Pharmaceuticals Inc Reports Robust Revenue Growth and Strong Full-Year Performance
|
Feb 28 |
Amphastar Pharmaceuticals Non-GAAP EPS of $0.88 misses by $0.03, revenue of $178.1M beats by $4.77M
|
Feb 28 |
Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full-Year Ended December 31, 2023
|
Feb 27 |
Amphastar Pharmaceuticals Q4 2023 Earnings Preview
|
Feb 22 |
Amphastar Pharmaceuticals (AMPH) Increases Yet Falls Behind Market: What Investors Need to Know
|